167 related articles for article (PubMed ID: 11083532)
1. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach KW; Schicha H
Eur J Nucl Med; 2000 Oct; 27(10):1441-56. PubMed ID: 11083532
[TBL] [Abstract][Full Text] [Related]
2. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
Keith CJ; Miles KA; Griffiths MR; Wong D; Pitman AG; Hicks RJ
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1016-23. PubMed ID: 12173015
[TBL] [Abstract][Full Text] [Related]
3. [Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data].
Dietlein M; Moka D; Weber K; Theissen P; Schicha H
Nuklearmedizin; 2001 Aug; 40(4):122-8. PubMed ID: 11556202
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach KW; Schicha H
Eur J Nucl Med; 2000 Nov; 27(11):1598-609. PubMed ID: 11105815
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
Gould MK; Sanders GD; Barnett PG; Rydzak CE; Maclean CC; McClellan MB; Owens DK
Ann Intern Med; 2003 May; 138(9):724-35. PubMed ID: 12729427
[TBL] [Abstract][Full Text] [Related]
6. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
Wang YT; Huang G
Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
[TBL] [Abstract][Full Text] [Related]
7. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
Tsushima Y; Endo K
Med Sci Monit; 2004 May; 10(5):MT65-72. PubMed ID: 15114278
[TBL] [Abstract][Full Text] [Related]
8. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.
Lejeune C; Al Zahouri K; Woronoff-Lemsi MC; Arveux P; Bernard A; Binquet C; Guillemin F
Eur J Health Econ; 2005 Sep; 6(3):203-14. PubMed ID: 15834623
[TBL] [Abstract][Full Text] [Related]
9. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
10. Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.
Comber LA; Keith CJ; Griffiths M; Miles KA
Clin Radiol; 2003 Sep; 58(9):706-11. PubMed ID: 12943643
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.
Deppen SA; Davis WT; Green EA; Rickman O; Aldrich MC; Fletcher S; Putnam JB; Grogan EL
Ann Thorac Surg; 2014 Oct; 98(4):1214-22. PubMed ID: 25087933
[TBL] [Abstract][Full Text] [Related]
12. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Scott WJ; Shepherd J; Gambhir SS
Ann Thorac Surg; 1998 Dec; 66(6):1876-83; discussion 1883-5. PubMed ID: 9930463
[TBL] [Abstract][Full Text] [Related]
14. Medical economics of whole-body FDG PET in patients suspected of having non-small cell lung carcinoma--reassessment based on the revised Japanese national insurance reimbursement system.
Abe K; Kosuda S; Kusano S
Ann Nucl Med; 2003 Dec; 17(8):649-55. PubMed ID: 14971606
[TBL] [Abstract][Full Text] [Related]
15. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
Chest; 2000 Feb; 117(2):346-53. PubMed ID: 10669673
[TBL] [Abstract][Full Text] [Related]
16. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
Spadafora M; Evangelista L; Gridelli C; Cuocolo A
Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
[TBL] [Abstract][Full Text] [Related]
17. [Whether and under what conditions FDG-PET might be cost-effective in evaluating solitary pulmonary nodules depicted on lung cancer screening in Japan].
Tsushima Y; Aoki J; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):390-8. PubMed ID: 14587408
[TBL] [Abstract][Full Text] [Related]
18. Analytical decision model for the cost-effective management of solitary pulmonary nodules.
Gambhir SS; Shepherd JE; Shah BD; Hart E; Hoh CK; Valk PE; Emi T; Phelps ME
J Clin Oncol; 1998 Jun; 16(6):2113-25. PubMed ID: 9626211
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Hollenbeak CS; Lowe VJ; Stack BC
Cancer; 2001 Nov; 92(9):2341-8. PubMed ID: 11745289
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
